Evidence map›Paper›PMID 38591203›Full record

ReviewCurrent topics in medicinal chemistry2024

Prominent Perspective on Existing Biological Hallmarks of Alzheimer's Disease.

Namrata Singh, Srishti Sharma, Kallol K Ghosh, Bhanushree Gupta, Kamil Kuca

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current topics in medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Namrata SinghDepartment of Engineering Science, Ramrao Adik Institute of Technology, DY Patil University, Navi Mumbai, 400706, India.
Srishti SharmaSchool of Studies in Chemistry, Pt. Ravishankar Shukla University, Raipur, 492010 (C.G.), India.
Kallol K GhoshSchool of Studies in Chemistry, Pt. Ravishankar Shukla University, Raipur, 492010 (C.G.), India.
Bhanushree GuptaCentre of Basic Sciences, Pt. Ravishankar Shukla University, Raipur, 492010 (C.G.), India.
Kamil KucaDepartment of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003, Hradec Kralove, Czech Republic.ORCID 0000-0001-9664-1109

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomarkers are the most significant diagnosis tools tending towards unique approaches and solutions for the prevention and cure of Alzheimer's Disease (AD). The current report provides a clear perception of the concept of various biomarkers and their prominent features through analysis to provide a possible solution for the inhibition of events in AD. Scientists around the world truly believe that crucial hallmarks can serve as critical tools in the early diagnosis, cure, and prevention, as well as the future of medicine. The awareness and understanding of such biomarkers would provide solutions to the puzzled mechanism of this neuronal disorder. Some of the argued biomarkers in the present article are still in an experimental phase as they need to undergo specific clinical trials before they can be considered for treatment.

Indexed as

Alzheimer DiseaseBiomarkersAmyloid beta-PeptidesHumanstau ProteinsAmyloid beta-PeptidesBiomarkerstau ProteinsAlzheimer’s diseasebiomarkersdiagnosis.neurodegenerative diseasestau proteinβ-amyloid peptide

Identifiers

PMID38591203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.